All In MedTech

Device Trial Radar · NCT05361967

Tack Optimized Balloon Angioplasty Post-Market Study

Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

6

Actual

Start

Mar 30, 2023

Primary completion

Jun 1, 2024

Study completion Jun 1, 2024

Sponsor

Lead sponsor
Spectranetics CorporationNot on our public-company list
Sponsor type
Industry
First posted
May 5, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.

Conditions

  • PAD - Peripheral Arterial Disease
  • PAD
  • Dissection
  • Arterial Dissection
  • Peripheral Arterial Disease
  • Peripheral Vascular Diseases

Interventions

  • The Tack Endovascular SystemDevice

    The Tack Endovascular System is designed to treat vascular dissections with Tack implant(s) following angioplasty.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedure SuccessTime frame: Measured on Day 0 of enrollment, upon completion of the Index Procedure

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Advanced Heart and Vein Center - Thornton

    Thornton, Colorado

  • Hartford Hospital

    Hartford, Connecticut

  • Palm Vascular Center Research

    Fort Lauderdale, Florida

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.